Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 134

    1.

    The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology.

    Finger PT; 7th Edition, AJCC-UICC Ophthalmic Oncology Task Force.

    Arch Pathol Lab Med. 2009 Aug;133(8):1197-8. No abstract available. PMID: 19653708 [PubMed - indexed for MEDLINE]Related articles

    2.

    Episodic Src activation in uveal melanoma revealed by kinase activity profiling.

    Maat W, el Filali M, Dirks-Mulder A, Luyten GP, Gruis NA, Desjardins L, Boender P, Jager MJ, van der Velden PA.

    Br J Cancer. 2009 Jul 21;101(2):312-9. Epub 2009 Jun 30.PMID: 19568237 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cutaneous allergy testing in patients suspected of an allergic reaction to eye medication.

    Wijnmaalen AL, van Zuuren EJ, de Keizer RJ, Jager MJ.

    Ophthalmic Res. 2009;41(4):225-9. Epub 2009 May 15.PMID: 19451736 [PubMed - indexed for MEDLINE]Related articles

    4.

    IL-10 promotor haplotypes associated with susceptibility to and severity of bacterial corneal ulcers.

    Keijser S, Kurreeman FA, de Keizer RJ, Dogterom-Ballering H, van der Lelij A, Jager MJ, Nibbering PH.

    Exp Eye Res. 2009 Jun;88(6):1124-8. Epub 2009 Feb 10.PMID: 19450443 [PubMed - indexed for MEDLINE]Related articles

    5.

    Melanoma vaccines: The problems of local immunosuppression.

    Polak ME, Borthwick NJ, Jager MJ, Cree IA.

    Hum Immunol. 2009 May;70(5):331-9.PMID: 19405172 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

    Maat W, van der Slik AR, Verhoeven DH, Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J.

    Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2888-95. Epub 2009 Feb 21.PMID: 19234348 [PubMed - indexed for MEDLINE]Related articles

    7.

    Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.

    El Filali M, Homminga I, Maat W, van der Velden PA, Jager MJ.

    Mol Vis. 2008 Sep 24;14:1752-9.PMID: 18836566 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A Dutch guideline for the treatment of scoliosis in neuromuscular disorders.

    Mullender M, Blom N, De Kleuver M, Fock J, Hitters W, Horemans A, Kalkman C, Pruijs J, Timmer R, Titarsolej P, Van Haasteren N, Jager MV, Van Vught A, Van Royen B.

    Scoliosis. 2008 Sep 26;3:14.PMID: 18822133 [PubMed - in process]Related articlesFree article

    9.

    Authenticating cell lines in ophthalmic research laboratories.

    Folberg R, Kadkol SS, Frenkel S, Valyi-Nagy K, Jager MJ, Pe'er J, Maniotis AJ.

    Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4697-701. Epub 2008 Aug 8. Review. No abstract available. PMID: 18689700 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Expression and distribution of MMPs and TIMPs in human uveal melanoma.

    Lai K, Conway RM, Crouch R, Jager MJ, Madigan MC.

    Exp Eye Res. 2008 Jun;86(6):936-41. Epub 2008 Mar 16.PMID: 18423620 [PubMed - indexed for MEDLINE]Related articles

    11.

    Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.

    Maat W, Beiboer SH, Jager MJ, Luyten GP, Gruis NA, van der Velden PA.

    Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1291-8.PMID: 18385040 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Activation of tonsil dendritic cells with immuno-adjuvants.

    Polak ME, Borthwick NJ, Gabriel FG, Jager MJ, Cree IA.

    BMC Immunol. 2008 Mar 18;9:10.PMID: 18366670 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes.

    Hallermalm K, Seki K, De Geer A, Motyka B, Bleackley RC, Jager MJ, Froelich CJ, Kiessling R, Levitsky V, Levitskaya J.

    J Immunol. 2008 Mar 15;180(6):3766-74.PMID: 18322182 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.

    Maat W, Ly LV, Jordanova ES, de Wolff-Rouendaal D, Schalij-Delfos NE, Jager MJ.

    Invest Ophthalmol Vis Sci. 2008 Feb;49(2):505-10.PMID: 18234992 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.

    Maat W, Kilic E, Luyten GP, de Klein A, Jager MJ, Gruis NA, Van der Velden PA.

    Invest Ophthalmol Vis Sci. 2008 Jan;49(1):23-7.PMID: 18172070 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lactoferrin Glu561Asp polymorphism is associated with susceptibility to herpes simplex keratitis.

    Keijser S, Jager MJ, Dogterom-Ballering HC, Schoonderwoerd DT, de Keizer RJ, Krose CJ, Houwing-Duistermaat JJ, van der Plas MJ, van Dissel JT, Nibbering PH.

    Exp Eye Res. 2008 Jan;86(1):105-9. Epub 2007 Oct 7.PMID: 18022620 [PubMed - indexed for MEDLINE]Related articles

    17.

    Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma.

    Zuidervaart W, Pavey S, van Nieuwpoort FA, Packer L, Out C, Maat W, Jager MJ, Gruis NA, Hayward NK.

    Melanoma Res. 2007 Dec;17(6):380-6.PMID: 17992121 [PubMed - indexed for MEDLINE]Related articles

    18.

    Macrophages feel their age in macular degeneration.

    Jager MJ, Klaver CC.

    J Clin Invest. 2007 Nov;117(11):3182-4.PMID: 17975664 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.

    Holling TM, Bergevoet MW, Wilson L, Van Eggermond MC, Schooten E, Steenbergen RD, Snijders PJ, Jager MJ, Van den Elsen PJ.

    J Immunol. 2007 Oct 15;179(8):5317-25.PMID: 17911618 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Expression and distribution of MUC18 in human uveal melanoma.

    Lai K, Sharma V, Jager MJ, Conway RM, Madigan MC.

    Virchows Arch. 2007 Nov;451(5):967-76. Epub 2007 Sep 5.PMID: 17786470 [PubMed - indexed for MEDLINE]Related articles

    21.

    Mechanisms of local immunosuppression in cutaneous melanoma.

    Polak ME, Borthwick NJ, Gabriel FG, Johnson P, Higgins B, Hurren J, McCormick D, Jager MJ, Cree IA.

    Br J Cancer. 2007 Jun 18;96(12):1879-87. Epub 2007 Jun 12.PMID: 17565341 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Presence and phenotype of dendritic cells in uveal melanoma.

    Polak ME, Borthwick NJ, Johnson P, Hungerford JL, Higgins B, Di Palma S, Jager MJ, Cree IA.

    Br J Ophthalmol. 2007 Jul;91(7):971-6. Epub 2007 Mar 8.PMID: 17347328 [PubMed - indexed for MEDLINE]Related articles

    23.

    S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests.

    Missotten GS, Korse CM, van Dehn C, Linders TC, Keunen JE, Jager MJ, Bonfrer JM.

    Tumour Biol. 2007;28(2):63-9. Epub 2007 Jan 29.PMID: 17264538 [PubMed - indexed for MEDLINE]Related articles

    24.

    Epigenetic inactivation of RASSF1a in uveal melanoma.

    Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA.

    Invest Ophthalmol Vis Sci. 2007 Feb;48(2):486-90.PMID: 17251440 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.

    Maat W, Jordanova ES, van Zelderen-Bhola SL, Barthen ER, Wessels HW, Schalij-Delfos NE, Jager MJ.

    Arch Pathol Lab Med. 2007 Jan;131(1):91-6.PMID: 17227129 [PubMed - indexed for MEDLINE]Related articles

    26.

    The effect of ultraviolet radiation on choroidal melanocytes and melanoma cell lines: cell survival and matrix metalloproteinase production.

    Lai K, Di Girolamo N, Conway RM, Jager MJ, Madigan MC.

    Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):715-24. Epub 2006 Oct 17.PMID: 17043807 [PubMed - indexed for MEDLINE]Related articles

    27.

    Vascular endothelial growth factor a in eyes with uveal melanoma.

    Missotten GS, Notting IC, Schlingemann RO, Zijlmans HJ, Lau C, Eilers PH, Keunen JE, Jager MJ.

    Arch Ophthalmol. 2006 Oct;124(10):1428-34.PMID: 17030710 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Angiogenesis in uveal melanoma.

    Jager MJ.

    Ophthalmic Res. 2006;38(5):248-50. Epub 2006 Aug 15. No abstract available. PMID: 16912514 [PubMed - indexed for MEDLINE]Related articles

    29.

    A new model for limbal transplantation using E-GFP for follow-up of transplant survival.

    Keijser S, de Keizer RJ, Prins FA, Tanke HJ, van Rooijen N, Vrensen GF, Jager MJ.

    Exp Eye Res. 2006 Nov;83(5):1188-95. Epub 2006 Jul 31.PMID: 16879820 [PubMed - indexed for MEDLINE]Related articles

    30.

    Epigenetic silencing of MHC2TA transcription in cancer.

    Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ.

    Biochem Pharmacol. 2006 Nov 30;72(11):1570-6. Epub 2006 Aug 1. Review.PMID: 16879803 [PubMed - indexed for MEDLINE]Related articles

    31.

    Macrophages are vital in spontaneous intraocular tumor eradication.

    Boonman ZF, Schurmans LR, van Rooijen N, Melief CJ, Toes RE, Jager MJ.

    Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2959-65.PMID: 16799039 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells.

    Vertuani S, Dubrovska E, Levitsky V, Jager MJ, Kiessling R, Levitskaya J.

    Cancer Immunol Immunother. 2007 Feb;56(2):193-204. Epub 2006 Jun 3.PMID: 16752155 [PubMed - indexed for MEDLINE]Related articles

    33.

    Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.

    Zuidervaart W, Hensbergen PJ, Wong MC, Deelder AM, Tensen CP, Jager MJ, Gruis NA.

    Invest Ophthalmol Vis Sci. 2006 Mar;47(3):786-93.PMID: 16505008 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.

    Keijser S, Missotten GS, Bonfrer JM, de Wolff-Rouendaal D, Jager MJ, de Keizer RJ.

    Br J Ophthalmol. 2006 Feb;90(2):213-7.PMID: 16424536 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.

    Maat W, Haasnoot GW, Claas FH, Schalij-Delfos NE, Schreuder GM, Jager MJ.

    Invest Ophthalmol Vis Sci. 2006 Jan;47(1):3-6.PMID: 16384937 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Normal HLA class I, II, and MICA gene distribution in uveal melanoma.

    Metzelaar-Blok JA, Hurks HM, Naipal A, De Lange P, Keunen JE, Claas FH, Doxiadis II, Jager MJ.

    Mol Vis. 2005 Dec 21;11:1166-72.PMID: 16379028 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.

    Li Y, Wang J, Rizvi SM, Jager MJ, Conway RM, Billson FA, Allen BJ, Madigan MC.

    Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4365-71.PMID: 16303921 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Maintenance of immune tolerance depends on normal tissue homeostasis.

    Boonman ZF, van Mierlo GJ, Fransen MF, de Keizer RJ, Jager MJ, Melief CJ, Toes RE.

    J Immunol. 2005 Oct 1;175(7):4247-54.PMID: 16177064 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Ciliary tissue transplantation in the rabbit.

    Jovanovik-Pandova L, Watson PG, Liu C, Chan WY, de Wolff-Rouendaal D, Barthen ER, Emmanouilidis-van der Spek K, Jager MJ.

    Exp Eye Res. 2006 Feb;82(2):247-57. Epub 2005 Jul 28.PMID: 16054623 [PubMed - indexed for MEDLINE]Related articles

    40.

    Presence and maturity of dendritic cells in melanoma lymph node metastases.

    Polak ME, Johnson P, Di Palma S, Higgins B, Hurren J, Borthwick NJ, Jager MJ, Mccormick D, Cree IA.

    J Pathol. 2005 Sep;207(1):83-90.PMID: 15983979 [PubMed - indexed for MEDLINE]Related articles

    41.

    Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.

    Zuidervaart W, van Nieuwpoort F, Stark M, Dijkman R, Packer L, Borgstein AM, Pavey S, van der Velden P, Out C, Jager MJ, Hayward NK, Gruis NA.

    Br J Cancer. 2005 Jun 6;92(11):2032-8.PMID: 15928660 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.

    Notting IC, Buijs JT, Que I, Mintardjo RE, van der Horst G, Karperien M, Missotten GS, Jager MJ, Schalij-Delfos NE, Keunen JE, van der Pluijm G.

    Invest Ophthalmol Vis Sci. 2005 May;46(5):1581-7.PMID: 15851554 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.

    van Dinten LC, Pul N, van Nieuwpoort AF, Out CJ, Jager MJ, van den Elsen PJ.

    Invest Ophthalmol Vis Sci. 2005 Jan;46(1):24-30.PMID: 15623750 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction.

    Boonman ZF, van Mierlo GJ, Fransen MF, Franken KL, Offringa R, Melief CJ, Jager MJ, Toes RE.

    J Immunol. 2004 Feb 1;172(3):1567-74.PMID: 14734736 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration.

    Bosscha MI, van Dissel JT, Kuijper EJ, Swart W, Jager MJ.

    Br J Ophthalmol. 2004 Jan;88(1):25-8.PMID: 14693766 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.

    Zuidervaart W, van der Velden PA, Hurks MH, van Nieuwpoort FA, Out-Luiting CJ, Singh AD, Frants RR, Jager MJ, Gruis NA.

    Br J Cancer. 2003 Nov 17;89(10):1914-9.PMID: 14612903 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Prognostic value of the disodium phosphate 32P uptake test in uveal melanoma: a long-term study.

    Overkleeft EN, Zuidervaart W, Hurks HM, Eilers PH, de Wolff-Rouendaal D, Jager MJ.

    Arch Ophthalmol. 2003 Oct;121(10):1398-403.PMID: 14557175 [PubMed - indexed for MEDLINE]Related articles

    48.

    MICA association with presumed ocular histoplasmosis syndrome (POHS).

    Reinders J, Rozemuller EH, Ongkosuwito JV, Jager MJ, Tilanus MG, Suttorp-Schulten MS.

    Mol Vis. 2003 Sep 2;9:420-4.PMID: 12963865 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.

    Wang S, Boonman ZF, Li HC, He Y, Jager MJ, Toes RE, Niederkorn JY.

    J Immunol. 2003 Sep 15;171(6):2789-96.PMID: 12960299 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    The value of combining anterior segment fluorescein angiography with indocyanine green angiography in scleral inflammation.

    Nieuwenhuizen J, Watson PG, Emmanouilidis-van der Spek K, Keunen JE, Jager MJ.

    Ophthalmology. 2003 Aug;110(8):1653-66. Erratum in: Ophthalmology. 2004 Feb;111(2):331. PMID: 12917189 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...